Table 1.
Baseline characteristics of patients with advanced HCC enrolled in this study
| Cohort 1 |
Cohort 2 |
Cohort 3 |
Total |
||
|---|---|---|---|---|---|
| Characteristics | No. of Patients | 6 | 6 | 6 | 18 |
| Age, years | 50–59 | 1 | 1 | 2 | 4 |
| 60–69 | 4 | 3 | 2 | 9 | |
| 70–79 | 0 | 3 | 2 | 5 | |
| 80–89 | 1 | 0 | 0 | 1 | |
| PS | 0 | 6 | 6 | 6 | 18 |
| 1 | 0 | 0 | 0 | 0 | |
| Viral marker | HBsAg (+) | 2 | 0 | 3 | 5 |
| HCV-Ab (+) | 3 | 4 | 2 | 9 | |
| Both negative | 1 | 2 | 1 | 4 | |
| Child-Pugh score | 5 | 3 | 4 | 3 | 10 |
| 6 | 3 | 2 | 3 | 8 | |
| Portal vein invasion | Absent | 5 | 4 | 3 | 12 |
| Present | 1 | 2 | 3 | 6 | |
| Distant metastasis | Absent | 6 | 6 | 6 | 18 |
| Present | 0 | 0 | 0 | 0 | |
| Stage | III | 5 | 4 | 3 | 12 |
| IVA | 1 | 2 | 3 | 6 |
PS=performance status; HBsAg=hepatitis B virus soluble antigen; HCV-Ab=HCV antibody.